Experimental injection aims to protect vision in High-Risk eye surgery
NCT ID NCT06926478
Summary
This early-stage study is testing whether a single injection of the drug adalimumab (Humira) given during an artificial cornea implant surgery is safe. The surgery, called a Boston Keratoprosthesis, is for people with severe, vision-threatening corneal damage who have few other options. Researchers will monitor 8 participants for 30 days after surgery to check for side effects and see if the injection might help reduce complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEVENS-JOHNSON SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.